This effect impeded the binding of kinase (MEK1) to the substrate (ERK2), preventing the phosphorylation of ERK2, finally resulting in suppression of ICC proliferation and metastasis (Fig. 7G). The gene discussed is MAPK1; the disease is intrahepatic cholangiocarcinoma.